Crombet T - Search Results

1

EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects.

Perez R, Moreno E, Garrido G, Crombet T. Perez R, et al. Among authors: crombet t. Cancers (Basel). 2011 Apr 18;3(2):2014-31. doi: 10.3390/cancers3022014. Cancers (Basel). 2011. PMID: 24212794 Free PMC article.

2

Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor.

Crombet T, Torres O, Neninger E, Catalá M, Rodríguez N, Ramos M, Fernández E, Iznaga N, Pérez R, Lage A. Crombet T, et al. Cancer Biother Radiopharm. 2001 Feb;16(1):93-102. doi: 10.1089/108497801750096122. Cancer Biother Radiopharm. 2001. PMID: 11279803 Clinical Trial.

3

Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: preliminary study.

Crombet T, Torres O, Rodríguez V, Menéndez A, Stevenson A, Ramos M, Torres F, Figueredo R, Veitía I, Iznaga N, Pérez R, Lage A. Crombet T, et al. Hybridoma. 2001 Apr;20(2):131-6. doi: 10.1089/02724570152057634. Hybridoma. 2001. PMID: 11394532 Clinical Trial.

4

Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy.

Gonzalez G, Crombet T, Torres F, Catala M, Alfonso L, Osorio M, Neninger E, Garcia B, Mulet A, Perez R, Lage R. Gonzalez G, et al. Among authors: crombet t. Ann Oncol. 2003 Mar;14(3):461-6. doi: 10.1093/annonc/mdg102. Ann Oncol. 2003. PMID: 12598354 Free article. Clinical Trial.

5

Pharmacological evaluation of humanized anti-epidermal growth factor receptor, monoclonal antibody h-R3, in patients with advanced epithelial-derived cancer.

Crombet T, Torres L, Neninger E, Catalá M, Solano ME, Perera A, Torres O, Iznaga N, Torres F, Pérez R, Lage A. Crombet T, et al. J Immunother. 2003 Mar-Apr;26(2):139-48. doi: 10.1097/00002371-200303000-00006. J Immunother. 2003. PMID: 12616105 Clinical Trial.

6

Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.

Crombet T, Osorio M, Cruz T, Roca C, del Castillo R, Mon R, Iznaga-Escobar N, Figueredo R, Koropatnick J, Renginfo E, Fernández E, Alvárez D, Torres O, Ramos M, Leonard I, Pérez R, Lage A. Crombet T, et al. J Clin Oncol. 2004 May 1;22(9):1646-54. doi: 10.1200/JCO.2004.03.089. J Clin Oncol. 2004. PMID: 15117987 Clinical Trial.

7

Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients.

Mulens V, de la Torre A, Marinello P, Rodríguez R, Cardoso J, Díaz R, O'Farrill M, Macias A, Viada C, Saurez G, Carr A, Crombet T, Mazorra Z, Perez R, Fernandez LE. Mulens V, et al. Among authors: crombet t. Hum Vaccin. 2010 Sep 14;6(9). Epub 2010 Sep 14. Hum Vaccin. 2010. PMID: 20855939

8

Bivalent binding by intermediate affinity of nimotuzumab: a contribution to explain antibody clinical profile.

Garrido G, Tikhomirov IA, Rabasa A, Yang E, Gracia E, Iznaga N, Fernández LE, Crombet T, Kerbel RS, Pérez R. Garrido G, et al. Among authors: crombet t. Cancer Biol Ther. 2011 Feb 15;11(4):373-82. doi: 10.4161/cbt.11.4.14097. Epub 2011 Feb 15. Cancer Biol Ther. 2011. PMID: 21150278

9

A view on EGFR-targeted therapies from the oncogene-addiction perspective.

Perez R, Crombet T, de Leon J, Moreno E. Perez R, et al. Among authors: crombet t. Front Pharmacol. 2013 Apr 26;4:53. doi: 10.3389/fphar.2013.00053. eCollection 2013. Front Pharmacol. 2013. PMID: 23637683 Free PMC article.

10

A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer patients.

Alfonso S, Valdés-Zayas A, Santiesteban ER, Flores YI, Areces F, Hernández M, Viada CE, Mendoza IC, Guerra PP, García E, Ortiz RA, de la Torre AV, Cepeda M, Pérez K, Chong E, Hernández AM, Toledo D, González Z, Mazorra Z, Crombet T, Pérez R, Vázquez AM, Macías AE. Alfonso S, et al. Among authors: crombet t. Clin Cancer Res. 2014 Jul 15;20(14):3660-71. doi: 10.1158/1078-0432.CCR-13-1674. Epub 2014 May 1. Clin Cancer Res. 2014. PMID: 24788102 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page